Takashi Taga - Concepedia

Author

Takashi Taga

Shiga University of Medical Science ORCID

Also Known As

Japanese Society of Pediatric Hematology Oncology (JSPHO), T Taga, T. Taga, Takashi TAGA, Takashi Taga, Yozo Nakazawa

255

Publications

4.2K

Citations

H-Index

102

Concepts

All Affiliations

Shiga University of Medical Science Kyoto University National Center For Child Health and Development National Hospital Organization Nagoya Medical Center

About

Takashi Taga is an author at Shiga University of Medical Science specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	37	1.2K
2	Health Sciences	6	6	155
3	Engineering	1	1	19
4	Natural Sciences	1	1	22
5	Public Health	1	1	20

Takashi Taga

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study Brian V. Balgobind, Susana C. Raimondi, Jochen Harbott, Blood	2009	444
Preferential Susceptibility of Brain Tumors to the Antiangiogenic Effects of an αv Integrin Antagonist Tobey J. MacDonald, Takashi Taga, Hiroyuki Shimada, Neurosurgery	2001	237
α<i>v</i>‐Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin Takashi Taga, Atsushi Suzuki, Ignacio González-Gómez, International Journal of Cancer	2002	196
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome Maurice Labuhn, Kelly Perkins, Sören Matzk, Cancer Cell Down SyndromeMyeloid PreleukemiaTransformed Myeloid LeukemiaHematological MalignancyMixed-phenotype Acute Leukemia	2019	140
Identification of Severe Combined Immunodeficiency by T-Cell Receptor Excision Circles Quantification Using Neonatal Guthrie Cards Yoichi Morinishi, Kohsuke Imai, Noriko Nakagawa, The Journal of Pediatrics Primary ImmunodeficiencySevere Combined ImmunodeficiencyAutoimmune DiseaseAllergyImmunodeficiencies	2009	120
Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease Eitaro Hiejima, Tomoki Kawai, Hiroshi Nakase, Inflammatory Bowel Diseases	2015	101
Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia Rika Kanezaki, Tsutomu Toki, Kiminori Terui, Blood	2010	99
Clinical Impact of Additional Cytogenetic Aberrations, <i>cKIT</i> and <i>RAS</i> Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group Kim Klein, Gertjan J.L. Kaspers, Christine J. Harrison, Journal of Clinical Oncology	2015	92
Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia Norio Shiba, Kenichi Yoshida, Yusuke Hara, Blood Advances	2019	81
Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study Hiroto Inaba, Yinmei Zhou, Oussama Abla, Blood	2015	78

Page 1